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The Editorial on the Research Topic
Endophenotypes for schizophrenia and mood disorders: implications from genetic, biochemical, 
cognitive, behavioral, and neuroimaging studies
Schizophrenia and mood disorders represent complex phenotypes that are characterized by multidi-
mensional psychopathology and biological underpinnings. After many years of clinical observations, 
it has been recognized that there are several intermediate phenotypes between schizophrenia and 
mood disorders that share common clinical characteristics. This observation has provided grounds 
for the concept of endophenotypes, crossing traditional diagnostic boundaries and opening per-
spectives for better understanding of mental disorders. Indeed, the term endophenotype refers to a 
measurable construct that bridges a gap between phenotype expression and genetic variability. This 
intermediate phenotype construct must meet four characteristics: the association with illness in the 
population, heritability, state-independent manifestation (expression of the phenotype regardless 
of the illness activity), and cosegregation with illness in families (1). Consequently, a number of 
promising genetic, biochemical, cognitive, behavioral, and neuroimaging endophenotypes emerged 
providing a broader insight into the nature of schizophrenia and mood disorders.
In this research topic, a few promising candidates of clinical, biochemical, and neuroimaging 
endophenotypes have been proposed. Grant describes various aspects of schizotypy and proposes 
that schizotypy itself might be a suitable endophenotype of schizophrenia. Following the definition 
of endophenotype developed by Gottesman and Gould (1), the author indicates that schizophrenia 
patients have high levels of schizotypy that are even higher than in other psychotic disorders. Grant 
also provides evidence that schizotypy is highly heritable and cosegregates with schizophrenia with 
the illness in families. Additionally, it has been reported that healthy relatives of schizophrenia 
patients have higher levels of schizotypy than healthy individuals with negative family history of 
schizophrenia. Finally, Grant shows that schizotypy is a stable trait with high test–retest reliability in 
patients with schizophrenia. However, it should be noted that higher levels of schizotypy have been 
also reported in patients with bipolar disorder (BD) (2–4). Therefore, future studies should focus on 
determining the validity of schizotypy together with its specific dimensions as an endophenotype of 
schizophrenia or BD.
In two studies, the role of structural and functional brain alterations as potential endophenotypes 
of psychosis dimension has been investigated. In the large and multisite bipolar–schizophrenia net-
work on intermediate phenotypes (B-SNIP) study, Wang et al. found that functional alterations in 
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a prefrontal–striatal–thalamic–cerebellar network and  structural 
disturbances in the default mode network are common abnor-
malities across various psychotic disorders. Based on the data 
from B-SNIP study, Soh et al. performed joint independent com-
ponent analysis of awake EEG frequency activity and MRI gray 
matter volumes in patients with psychotic disorders. Authors 
found a single component differentiating schizophrenia patients 
and healthy individuals. Specifically, they reported increased 
posterior alpha activity associated with decreased volume in 
inferior parietal lobe, supramarginal, parahippocampal gyrus, 
middle frontal, inferior temporal gyri, and increased volume of 
uncus and culmen in patients with schizophrenia.
In the last article, Kim et al. in their mini review proposed that 
phospholipase C-β1 (PLC-β1) hypofunction might be an endo-
phenotype of schizophrenia. This enzyme is involved in phospho-
inositide signaling, which is one of the main G-protein-related 
pathways in the central nervous system. It has been reported 
that PLC-β1−/− mice express several negative-like symptoms and 
cognitive deficits that resemble those observed in schizophrenia 
(5–7). In addition, lower PLC-β1 has been found in several brain 
regions of patients with schizophrenia (8). Interestingly, the role 
of aberrant phospholipase C-γ1 (PLC-γ1) signaling has been also 
implicated in the pathophysiology of BD [for review, see Ref. (9)). 
In addition, polymorphism of the PLC-γ1 gene has been found 
to predict response to lithium treatment (10). A recent analysis 
of data from the genome-wide association study (GWAS) also 
revealed that genetic variation in phospholipase C signaling might 
be associated with a risk of BD (11). Therefore, more research 
is needed to disentangle the role of impaired phospholipase C 
signaling as an endophenotype for both schizophrenia and BD.
Although a number of candidate endophenotypes for 
schizophrenia and psychotic disorders have been proposed in 
this research topic, studies replicating these findings in large 
samples are required. In addition, future studies must look at 
these findings in a broader context of endophenotype criteria 
and verify how well they suit their original purpose  –  linking 
less complex disease phenotype to its genetic underpinnings. It 
is important to note that studies investigating endophenotypes 
should take into account that psychosis dimension is itself a 
heterogeneous construct. Indeed, psychotic symptoms associ-
ated with schizophrenia have different features compared to 
those observed in BD. For instance, most psychotic features 
associated with manic episodes tend to have a different, usually 
self-limited and self-remitting course. These symptoms appear 
in most severe episodes of BD. On the contrary, psychotic 
symptoms in schizophrenia have a more long-lasting course. 
This observation give rise to the conclusion that more objective 
and reliable endophenotypes offer a prospect of defining more 
etiologically homogenous subgroups of human psychopathol-
ogy and thus facilitate our understanding of the basis and causal 
pathways of mental disorders. Finally, the existence of relevant 
endophenotypes should initiate discussion about reappraisal of 
the research diagnostic criteria beyond traditional diagnostic 
systems to enable better understanding of mechanisms underly-
ing schizophrenia and mood disorders.
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